Radiographic Evaluation of a Star-shaped Incision Technique

Sponsor
Wen Luo (Other)
Overall Status
Completed
CT.gov ID
NCT05190614
Collaborator
(none)
24
1
24
1

Study Details

Study Description

Brief Summary

To evaluate a star-shaped incision technique to thick-gingiva and thingingiva patients treated with implant-supported fixed prosthesis. The star-shaped incision would be an effective and simple method to reconstruct gingival papillae and avoid the gingival recession in thick-gingiva patients treated with implant-supported fixed prosthesis, and it is worthy of clinical extend.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: The biotype of gingiva

Detailed Description

Objective: To evaluate a star-shaped incision technique to thick-gingiva and thin-gingiva patients treated with implant-supported fixed prosthesis. Methods and Materials: 24 patients received cross-shaped incision were assigned into thick-gingiva group (16 cases) and thin-gingiva group (8 cases). Follow-up examination was carried out 3 and 12 months after final restoration. Clinical and radiographic evaluation including gingival papilla height, modified plaque index, modified sulcus bleeding index, periodontal depth, and crestal marginal bone level were utilized.

Study Design

Study Type:
Observational
Actual Enrollment :
24 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Radiographic Evaluation of a Star-shaped Incision Technique for Thick-gingiva and Thin-gingiva Patients Treated With Implant-supported Fixed Prosthesis: a Randomized Trial
Actual Study Start Date :
Jun 1, 2019
Actual Primary Completion Date :
Jun 1, 2021
Actual Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
thick-gingiva group

After the insertion of the probe into the facial aspect of the sulcus through the gingival margin, the simple visual method is based on the transparency of the periodontal probe through the gingival margin while probing the buccal sulcus at the midfacial aspect of the tooth. When the outline of the underlying periodontal probe can't be seen through the gingival, the gingival phenotype is considered thick.

thin-gingiva group

After the insertion of the probe into the facial aspect of the sulcus through the gingival margin, the simple visual method is based on the transparency of the periodontal probe through the gingival margin while probing the buccal sulcus at the midfacial aspect of the tooth. When the outline of the underlying periodontal probe can be seen through the gingival, the gingival phenotype is considered thin.

Diagnostic Test: The biotype of gingiva
The biotype of gingival was determined by periodontal probe.

Outcome Measures

Primary Outcome Measures

  1. Papilla height [Between June 2019 and June 2021]

    Presence/absence of papilla height was assessed visually according to the papilla index proposed by Jemt

  2. Modified Plaque Index (mPI) [Between June 2019 and June 2021]

    plaque accumulation around the marginal peri-implant tissue was assessed by the criteria of mPI

  3. Modified Sulcus Bleeding Index (mBI) [Between June 2019 and June 2021]

    the bleeding tendency of the marginal peri-implant tissue was evaluated using mBI

  4. Probing Depth (PD, mm) [Between June 2019 and June 2021]

    PD was assessed at the mid-buccal, mid-oral, mesial and distal aspects of the buccal surfaces of each implant with a standard periodontal probe, and final value was determined by the average of four aspects.

  5. Gingival margin level (GML) [Between June 2019 and June 2021]

    gingival margin level was assessed by calculating the vertical distance between the most apical point of gingival margin at the buccal aspect of the crown and line connecting the peak of the adjacent mesial and distal natural teeth (PMD)

  6. The landmarks of first bone-implant contact (fBIC) and implant shoulder (IS) [Between June 2019 and June 2021]

    fBIC-IS was defined as the vertical distance the first bone-implant contact to implant shoulder, and the distance was assessed at the mesial and distal aspect of implant, respectively. When the marginal crestal bone was located coronal to the IS, a positive (+) value was given, where a negative (-) value when located apically to the IS, the value was deemed as zero when IS and fBIC coincided. The crestal bone level at the time of impression taking was regarded as baseline. The known implant length was used for the calibration of dimensional distortion in the radiograph (the length of implant was 10 mm).

Eligibility Criteria

Criteria

Ages Eligible for Study:
22 Years to 58 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Inclusion criteria

  1. Good general health, no chronic systemic diseases.

  2. All subjects included in this study needed to have one missing premolar or molar teeth with adjacent natural teeth.

  3. All subjects included in this study had been treated with one bone-level implant insertion in the premolar or molar region. The patients had insufficient gingival papilla height (referred to contralateral natural tooth which also had insufficient gingival papilla height) and at least 2 mm of keratinized tissue width around the implant.

Exclusion criteria

  1. Active periodontal infections.

  2. Heavy smoking (> 10 cigarettes per day).

Contacts and Locations

Locations

Site City State Country Postal Code
1 West China Hospital of Stomatology Chengdu Sichuan China 610041

Sponsors and Collaborators

  • Wen Luo

Investigators

  • Principal Investigator: Xiaohui Zheng, MD, West China Hospital of Stomatology, Sichuan University, China

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Wen Luo, Associate Professor, West China Hospital
ClinicalTrials.gov Identifier:
NCT05190614
Other Study ID Numbers:
  • 2019021
First Posted:
Jan 13, 2022
Last Update Posted:
Jan 13, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 13, 2022